Stock listing
NASDAQ:PBM Psyence Biomedical Ltd. Stock
Home listing (NASDAQ) of Psyence Biomedical Ltd.
Follow Psyence Biomedical Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:PBM
$3.31 USD -0.30 (-8.3%)
Close on Oct 30, 2026
- Day range
- $3.28 – $3.64 USDOct 30, 2026
- Volume
- 46,636 sharesOct 30, 2026
- Market cap
- $12.63M USDAt the close on Oct 30, 2026 · price × 3.81M shares outstanding
- 52-week range
- $1.92 – $20.63 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $387,217 USDMedian day 45,106 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PBM · Home | $3.31 USD | -0.30 (-8.3%) | 46,636 | $3.535 | $3.64 | $3.28 | $3.61 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:PBM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.31 | -0.30 | -8.3% | $3.535 | $3.64 | $3.28 | 46,636 | |
| $3.61 | +0.21 | +6.2% | $3.40 | $3.98 | $3.40 | 61,959 | |
| $3.40 | +0.39 | +13.0% | $3.00 | $3.44 | $2.985 | 32,848 | |
| $3.01 | -0.65 | -17.8% | $3.75 | $3.865 | $2.697 | 244,231 | |
| $3.66 | -0.505 | -12.1% | $4.06 | $4.18 | $3.63 | 45,711 | |
| $4.165 | +0.045 | +1.1% | $4.11 | $4.29 | $4.06 | 13,200 | |
| $4.12 | -0.40 | -8.8% | $4.39 | $4.768 | $4.12 | 56,400 | |
| $4.52 | +0.28 | +6.6% | $4.36 | $4.72 | $4.36 | 36,800 | |
| $4.24 | +0.12 | +2.9% | $4.09 | $4.51 | $4.06 | 44,500 | |
| $4.12 | -0.10 | -2.4% | $4.09 | $4.275 | $4.08 | 34,000 | |
| $4.22 | -0.10 | -2.3% | $4.34 | $4.53 | $4.16 | 26,500 | |
| $4.32 | +0.19 | +4.6% | $4.09 | $4.44 | $4.09 | 16,500 | |
| $4.13 | -0.42 | -9.2% | $4.53 | $4.821 | $4.10 | 68,200 | |
| $4.55 | -0.19 | -4.0% | $4.70 | $4.79 | $4.55 | 35,400 | |
| $4.74 | -0.23 | -4.6% | $4.88 | $5.041 | $4.73 | 25,300 | |
| $4.97 | -0.15 | -2.9% | $5.205 | $5.205 | $4.93 | 23,700 | |
| $5.12 | +0.24 | +4.9% | $4.88 | $5.22 | $4.86 | 67,100 | |
| $4.88 | -0.14 | -2.8% | $4.93 | $5.10 | $4.835 | 16,900 | |
| $5.02 | -0.06 | -1.2% | $5.08 | $5.30 | $4.89 | 50,300 | |
| $5.08 | -0.08 | -1.6% | $5.27 | $5.56 | $4.96 | 142,300 | |
| $5.16 | -0.32 | -5.8% | $5.52 | $5.633 | $5.12 | 75,100 | |
| $5.48 | +0.02 | +0.4% | $5.42 | $5.70 | $5.40 | 14,900 | |
| $5.46 | +0.03 | +0.6% | $5.43 | $5.721 | $5.38 | 17,800 | |
| $5.43 | -0.235 | -4.1% | $5.68 | $5.73 | $5.41 | 27,700 | |
| $5.665 | +0.105 | +1.9% | $5.59 | $5.82 | $5.51 | 48,300 | |
| $5.56 | -0.30 | -5.1% | $5.81 | $5.96 | $5.41 | 110,500 | |
| $5.86 | -0.45 | -7.1% | $6.19 | $6.37 | $5.61 | 137,500 | |
| $6.31 | +0.21 | +3.4% | $5.87 | $7.185 | $5.87 | 293,900 | |
| $6.10 | -0.42 | -6.4% | $6.50 | $6.50 | $5.85 | 179,200 | |
| $6.52 | -0.105 | -1.6% | $6.64 | $6.90 | $6.50 | 89,500 | |
| $6.625 | +0.305 | +4.8% | $6.30 | $6.85 | $6.19 | 134,400 | |
| $6.32 | +0.50 | +8.6% | $5.84 | $6.67 | $5.701 | 131,900 | |
| $5.82 | -0.25 | -4.1% | $6.03 | $6.06 | $5.80 | 40,400 | |
| $6.07 | +0.07 | +1.2% | $5.92 | $6.269 | $5.713 | 68,100 | |
| $6.00 | +0.60 | +11.1% | $5.44 | $6.14 | $5.39 | 172,600 | |
| $5.40 | +0.43 | +8.7% | $5.02 | $5.63 | $4.93 | 130,700 | |
| $4.97 | +0.13 | +2.7% | $4.73 | $5.12 | $4.681 | 56,500 | |
| $4.84 | +0.10 | +2.1% | $4.68 | $4.98 | $4.55 | 84,600 | |
| $4.74 | +0.20 | +4.4% | $4.58 | $4.848 | $4.53 | 69,200 | |
| $4.54 | +0.11 | +2.5% | $4.38 | $4.71 | $4.325 | 27,200 | |
| $4.43 | +0.06 | +1.4% | $4.31 | $4.60 | $4.26 | 21,400 | |
| $4.37 | 0.00 | 0.0% | $4.35 | $4.50 | $4.275 | 21,400 | |
| $4.37 | +0.03 | +0.7% | $4.30 | $4.37 | $4.21 | 15,200 | |
| $4.34 | +0.13 | +3.1% | $4.22 | $4.40 | $4.10 | 26,300 | |
| $4.21 | -0.10 | -2.3% | $4.37 | $4.37 | $4.185 | 14,700 | |
| $4.31 | -0.01 | -0.2% | $4.36 | $4.482 | $4.25 | 20,200 | |
| $4.32 | +0.05 | +1.2% | $4.28 | $4.495 | $4.28 | 42,600 | |
| $4.27 | +0.05 | +1.2% | $4.22 | $4.44 | $4.22 | 43,300 | |
| $4.22 | -0.11 | -2.5% | $4.29 | $4.34 | $4.14 | 37,500 | |
| $4.33 | +0.40 | +10.2% | $4.00 | $4.49 | $3.914 | 103,000 | |
| $3.93 | -0.17 | -4.1% | $4.02 | $4.02 | $3.73 | 58,100 | |
| $4.10 | -0.37 | -8.3% | $4.45 | $4.69 | $3.908 | 207,100 | |
| $4.47 | +0.86 | +23.8% | $3.60 | $5.00 | $3.52 | 898,200 | |
| $3.61 | +0.13 | +3.7% | $3.42 | $3.79 | $3.41 | 43,200 | |
| $3.48 | -0.08 | -2.2% | $3.51 | $3.57 | $3.43 | 18,600 | |
| $3.56 | +0.21 | +6.3% | $3.31 | $3.58 | $3.22 | 30,200 | |
| $3.35 | -0.05 | -1.5% | $3.38 | $3.485 | $3.31 | 23,500 | |
| $3.40 | -0.08 | -2.3% | $3.46 | $3.49 | $3.35 | 18,200 | |
| $3.48 | +0.01 | +0.3% | $3.50 | $3.55 | $3.462 | 29,100 | |
| $3.47 | -0.02 | -0.6% | $3.60 | $3.60 | $3.45 | 61,800 | |
| $3.49 | +0.20 | +6.1% | $3.23 | $3.58 | $3.23 | 120,000 | |
| $3.29 | +0.10 | +3.1% | $3.30 | $3.30 | $3.151 | 61,500 | |
| $3.19 | +0.04 | +1.3% | $3.15 | $3.30 | $3.08 | 32,800 | |
| $3.15 | -0.02 | -0.6% | $3.24 | $3.24 | $3.065 | 31,200 | |
| $3.17 | -0.19 | -5.7% | $3.21 | $3.24 | $3.05 | 70,400 | |
| $3.36 | +0.38 | +12.8% | $3.06 | $3.74 | $3.00 | 447,700 |
- Ticker
- NASDAQ:PBM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
Latest deck · Aug 6, 2026
Investor Presentation (August 2026)
Investor deck · 23 slides
Latest news
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
Oct 21, 2026
Closed $4.52 (+6.6%) on Oct 21, 2026
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Oct 5, 2026
Closed $5.08 (-1.6%) on Oct 5, 2026
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
Sep 28, 2026
Closed $5.67 (+1.9%) on Sep 28, 2026
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
May 15, 2026
Closed $4.91 (-2.6%) on May 15, 2026
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Apr 23, 2026
Closed $9.03 (+0.7%) on Apr 23, 2026
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
Apr 20, 2026
Closed $11.30 (+48.7%) on Apr 20, 2026
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
Apr 17, 2026
Closed $7.60 (+29.5%) on Apr 17, 2026
Pacific Bay & Aurwest Sign Weaver Gold Property Definitive Option/JV Agreement
Apr 14, 2026
Closed $2.95 (+5.7%) on Apr 14, 2026
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
Apr 8, 2026
Closed $2.49 (-0.4%) on Apr 8, 2026
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
Mar 11, 2026
Closed $2.49 (-0.8%) on Mar 11, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 23 slides · Aug 6, 2026
Investor Presentation (May 2025)
Investor deck · 41 slides · May 15, 2025
Investor Presentation (November 2024)
Investor deck · 33 slides · Nov 22, 2024
Investor Presentation (November 2024)
Investor deck · 33 slides · November 2024
Psyence Biomedical Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 74 in all · newest Oct 21, 2026 · oldest 2024
- Decks
- 9 decks · latest Aug 6, 2026
Where Psyence Biomedical Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PBM · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PBM | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Psyence Biomedical Ltd.